Cannabis medicines – an introduction
Wednesday 18th August, 11-12.30pm
If you’re living with a brain tumour diagnosis and wondering whether cannabis medicines might be relevant to you, come to this webinar.
This webinar will cover:
- The endocannabinoid system, different cannabinoids and what they can and can’t do.
- NICE guidelines, eligibility and how to access a prescription.
- A brief history of cannabis and it’s current status
- CBD, THC and other cannabinoid constituents and their effects
- What cannabis medicines look like and routes of administration
- Current UK licensed products
- Over the counter access vs prescriptions
- UK prescribing clinics
There will be an opportunity for you to ask your questions.
This webinar is being delivered by representatives from Grow, a biopharmaceutical company focused solely on cannabis based medicines and improving global access to those medicines. Proud to put patients at the heart of what they do, one of Grow’s missions is to educate people about cannabis medicines and to improve access to it where appropriate.
Click here to sign up to this webinar.
About our speakers
Alex Fraser, Patient Access Lead
Alex Fraser is a leading medical cannabis patient advocate. Diagnosed with Crohn’s Disease in 2010 at 19 years old, in 2014 he founded the United Patients Alliance. He has since appeared on mainstream media multiple times, including on the BBC and ITV, to highlight the urgent need for access to cannabis medicines for the many patients who may benefit from them.
He has taken delegations of patients to parliament to give testimony to politicians at the highest levels and organised educational events, rallies and protests calling for law change on medical cannabis. In Feb 2019 Alex joined Grow Pharma, one of the leading suppliers of cannabis medicines in the UK, as their patient access lead. He utilises his extensive knowledge of medical cannabis, his understanding of patient needs and his network in the industry to ensure patient voices are heard and represented.
His work includes informing top-level policy makers, educating healthcare professionals and conceiving and running projects that increase general awareness and provide practical help for patients.
Pierre van Weperen, CEO
Pierre joined Grow Group in 2019 after a 30+ year career in pharmaceutical industry in the Netherlands with stints in Germany and France and since 2007 in the UK. Starting out as a medical rep in the 90s, Pierre has held senior marketing and leadership roles in several top 10 global pharma companies. Just before joining Grow, Pierre managed Ashfield Healthcare services in the UK. Ashfield is the UKs largest pharmaceutical outsourcing provider and that is where he started working with medical cannabis for several companies who wanted to enter the UK market.
Pierre is inspired by Grow’s relentless focus on the patients who can benefit from medical cannabis and works with his team to train and educate HCPs, drive general awareness, lobby for regulatory changes and source the best products and innovations for patients. Being a patient himself, making a difference for patients drives him and that is also why he is chairman of the board of the Dutch MS patient association.
Pierre lives in North London with Freda and their daughter Isabella.